Preparation of 10B-enriched nitroimidazole derivative by click reaction as a functional drug for hypoxia-targeting boron-neutron capture therapy
We report a novel drug that can be used for the treatment of tumor hypoxic cells by boron neutron capture therapy. We attempted to modify p‑boronophenylalanine, a agent for this therapy in practical use, with a hypoxia-accumulating functional group, 2-nitroimidazole derivative to form p‑boronophenylalanine with nitroimidazole group (BPA-NI). We successfully prepared 10 B-enriched BPA-NI by using click chemistry between azide-modified p‑boronophenylalanine and alkyne-modified nitroimidazole in the presence of copper catalysis. This functional molecule showed selective accumulation in hypoxic cells, and therefore showed robust cytotoxic effects toward hypoxic cells upon thermal neutron irradiation.
Authors
- Kazuhito Tanabe (ORCID: https://orcid.org/0000-0003-2440-2293)
- Masaaki MIZUTANI
- TERUAKI OZASA
- Minoru Suzuki (ORCID: https://orcid.org/0000-0002-5421-9417)
- Tatsuya Nishihara (ORCID: https://orcid.org/0000-0002-6020-8757)
Institutions
- Aoyama Gakuin University (JP)
- Kyoto University (JP)
Publication Details
- Journal
- Results in Chemistry
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1016/j.rechem.2025.102245
- Citations
- 1
- Primary Topic
- Boron Compounds in Chemistry
- Type
- article
- Field-Weighted Citation Impact
- 1.36